Quadrant Capital Group LLC Xencor Inc Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Xencor Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,537 shares of XNCR stock, worth $19,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,537
Previous 2,958
14.23%
Holding current value
$19,205
Previous $67,000
61.19%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XNCR
# of Institutions
211Shares Held
78.4MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$84.1 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$73.9 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$59.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$46.5 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$29.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $452M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...